Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.660
-0.010 (-0.60%)
At close: Jul 23, 2026, 4:00 PM EDT
1.630
-0.030 (-1.81%)
After-hours: Jul 23, 2026, 7:34 PM EDT
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $2.47 million as of July 23, 2026. Its market cap has decreased by -57.50% in one year.
Market Cap
2.47M
Enterprise Value
-11.03M
1-Year Change
-57.50%
Ranking
Category
Stock Price
$1.66
ChartMarket Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.11M to $2.47M, a decrease of -90.56%. That is a compound annual growth rate of -38.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2026 | 2.47M | -9.16% |
| Dec 31, 2025 | 2.71M | -55.12% |
| Dec 31, 2024 | 6.05M | 27.16% |
| Dec 29, 2023 | 4.76M | -39.11% |
| Dec 30, 2022 | 7.81M | -59.09% |
| Dec 27, 2021 | 19.09M | -26.88% |
| Aug 16, 2021 | 26.11M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Onconetix | 3.25M |
| Creative Medical Technology Holdings | 3.11M |
| Virax Biolabs Group | 2.90M |
| SciSparc | 2.77M |
| Decoy Therapeutics | 2.63M |
| GRI Bio | 2.62M |
| Oragenics | 2.39M |
| CDT Equity | 2.13M |